Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-06-05 Transaction in Own Shar…
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled "TRANSACTIONS IN OWN SHARES" and details the purchase of ordinary shares by Indivior PLC for cancellation on June 4, 2024. It provides specific figures for shares purchased, highest/lowest/VWAP prices, and a detailed breakdown of individual transactions. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate filing type code is POS (Transaction in Own Shares). The document is also marked with an RNS Number and mentions RNS/London Stock Exchange, confirming it is a regulatory disclosure, but the content is highly specific to share repurchases.
2024-06-05 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-06-04 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'INDIVIOR PLC TRANSACTIONS IN OWN SHARES' and explicitly details the purchase of ordinary shares for cancellation on June 3, 2024, including the number of shares, highest/lowest/VWAP prices, and a full breakdown of individual purchases. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The RNS Number and reference to the London Stock Exchange confirm it is a regulatory filing, but the specific content maps precisely to the 'POS' code.
2024-06-04 English
TOTAL VOTING RIGHTS
Regulatory Filings
2024-06-03 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-06-03 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'TOTAL VOTING RIGHTS AND CAPITAL' and explicitly references the FCA's Disclosure Guidance and Transparency Rule 5.6.1. It states the total number of issued shares and voting rights as of a specific date (June 1, 2024) and notes that this figure is the denominator for shareholder notification calculations. This type of mandatory disclosure regarding the total share capital and voting rights is a standard regulatory announcement. Since it is a specific regulatory notification that doesn't fit the definitions for AGM-R, 10-K, ER, or DIV, the most appropriate general category for mandatory regulatory updates provided via RNS is 'Regulatory Filings' (RNS). Although it relates to capital structure, it is a notification of the total count, not a financing activity (CAP) or share issue (SHA). Given the source (RNS Number) and content, RNS is the best fit.
2024-06-03 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.